PDF(995 KB)
斯鲁利单抗联合化疗一线治疗PD-L1（CPS≥1）局部晚期或转移性食管鳞状细胞癌的成本-效用分析
赵荧荧, 居文祥, 张小涵, 路萝兰, 沈爱宗
中国医院药学杂志 ›› 2024, Vol. 44 ›› Issue (3) : 298-304.
PDF(995 KB)
PDF(995 KB)
斯鲁利单抗联合化疗一线治疗PD-L1（CPS≥1）局部晚期或转移性食管鳞状细胞癌的成本-效用分析
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Cost-utility analysis of serplulimab combined with chemotherapy in the first-line treatment of PD-L1 （CPS≥1） locally advanced or metastatic esophageal squamous cell carcinoma
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
